Baseline characteristic | Non-Obstetric Number, n (%)/Mean ± SD | Obstetric Number, n (%)/Mean ± SD | P value* |
---|---|---|---|
Mean age | 47.12 ± 17.53 | 28.67 ± 4.69 | < 0.001 |
Female Gender | 70(32.2%) | 43(100%) | < 0.001 |
Diabetes mellitus n(%) | 32(14.7%) | 1(2.3%) | 0.02 |
Hypertension n(%) | 54(24.8%) | 0(0%) | < 0.001 |
Cardiovascular disease n(%) | 18(8.2%) | 3(6.9%) | 1.0 |
Hypothyroidism n(%) | 2(0.9%) | 1(2.3%) | 0.42 |
Cerebrovascular disease n(%) | 4(1.8%) | 0(0%) | 1.0 |
Chronic liver disease n(%) | 20(9.2%) | 0(0%) | 0.05 |
Malignancy nn(%) | 6(2.7%) | 0(0%) | 0.59 |
Smoking n(%) | 57(26.3%) | 0(0%) | < 0.001 |
Alcohol n(%) | 46(21.2%) | 0(0%) | < 0.001 |
Oligo-anuric n(%) | 173(79.8%) | 37(86%) | < 0.001 |
Hypovolemic n(%) | 52(24%) | 2(4.6%) | < 0.001 |
Hypervolemic n(%) | 120(55.3%) | 38(88.3%) | 0.000 |
Vasopressors need n(%) | 122(56.2%) | 15(34.9%) | < 0.002 |
Mechanical ventilation n(%) | 67(30.9%) | 17(39.5%) | 0.28 |
eGFR at presentation (ml/min/1.73m2) | 19.2 ± 12.96 | 16.65 ± 13.12 | 0.23 |
ICU requirement n(%) | 68(31.3%) | 19(44.1%) | 0.10 |
KDIGO Stage 1 | 17(7.8%) | 5(11.6%) | |
KDIGO Stage 2 | 30(13.8%) | 1(2.3%) | < 0.08 |
KDIGO Stage 3 | 170(78.3%) | 37(86%) | |
TLC (∗103), per cu.mm | 17264.06 ± 10584.12 | 18926.51 ± 9338.74 | 0.11 |
Platelets (lakhs/cu.mm) | 1.88 ± 1.17 | 1.68 ± 1.40 | 0.07 |
Creatinine (mg %) | 5.13 ± 3.45 | 5.53 ± 4.28 | 0.62 |
Sodium (mmol/L) | 135.05 ± 7.73 | 135.37 ± 6.37 | 0.08 |
Albumin (g%) | 2.74 ± 0.77 | 2.63 ± 0.68 | 0.70 |
Uric Acid (mg%) | 9.10 ± 3.39 | 9.06 ± 3.74 | 0.51 |
LDH (U/L) | 268 (150.5–488) | 605 (290–2235) | < 0.001 |
CPK (U/L) | 50 (20-260.5) | 76 (23–193) | 0.39 |
Proteinuria (> 30 mg/dl) | 142(65.4%) | 36(83.27%) | < 0.02 |